BRD2 and neoplasm: NAT was not only associated with advanced stage (adjusted OR, 0.56; 95% CI, 0.33–0.93, p = 0.024) and tumor local invasion (adjusted OR, 0.60; 95% CI, 0.37–0.96, p = 0.034), but also exhibited a relationship with LNM (adjusted OR, 0.60; 95% CI, 0.37–0.99, p = 0.046), which demonstrated a stronger relationship with the aggressive characteristics to the all-gender cohort.